GW-515524B

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameGW-515524B
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 agonists
TargetsAdrenergic receptors alpha-1
Therapy Area/IndicationsUrinary Incontinence, Stress
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsUrinary Incontinence, Stress

Other Information

ATC CodeN/A
Related LinksN/A